
==== Front
Cardiol J
Cardiol J
Cardiology Journal
1897-5593
1898-018X
Via Medica

36385605
10.5603/CJ.a2022.0102
cardj-31-4-612
Clinical Cardiology: Original Article
The occurrence of cardiovascular risk factors and functioning in chronic illness in the Polish population of EUROASPIRE V
Kubica Aldona https://orcid.org/0000-0002-4608-0881
1
Pietrzykowski Łukasz https://orcid.org/0000-0001-7798-3138
1
Michalski Piotr https://orcid.org/0000-0001-9667-6096
1
Kasprzak Michał https://orcid.org/0000-0002-3465-4163
2
Ratajczak Jakub https://orcid.org/0000-0002-3059-5338
1
Siódmiak Joanna https://orcid.org/0000-0002-7374-9122
3
Fabiszak Tomasz https://orcid.org/0000-0001-7317-5088
2
Buczkowski Krzysztof https://orcid.org/0000-0002-7700-0952
4
Krintus Magdalena https://orcid.org/0000-0003-2627-7473
3
Jankowski Piotr https://orcid.org/0000-0001-6223-8821
56
1 Department of Cardiac Rehabilitation and Health Promotion, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Poland
2 Department of Cardiology and Internal Medicine, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Poland
3 Department of Laboratory Medicine, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Poland
4 Department of Family Medicine, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, Poland
5 Department of Internal Medicine and Geriatric Cardiology, Center of Postgraduate Medical Education, Warsaw, Poland
6 Department of Epidemiology and Health Promotion, School of Public Health, Center of Postgraduate Medical Education, Warsaw, Poland
Address for correspondence: Łukasz Pietrzykowski, PhD, APN, M.N.Sc, Department of Health Promotion, Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz, ul. M. Curie Skłodowskiej 9, 85–094 Bydgoszcz, Poland, tel/fax: +48 52 585 58 35, e-mail: lukasz.pietrzykowski@cm.umk.pl
2024
29 8 2024
31 4 612620
11 8 2022
29 9 2022
Copyright © 2024 Via Medica
2024
https://creativecommons.org/licenses/by-nc-nd/4.0/ This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
Background

The aim of this study was to assess the impact of cardiovascular risk on the functioning of patients without a history of atherosclerotic cardiovascular disease.

Methods

Two hundred patients diagnosed with arterial hypertension, hypercholesterolemia, or diabetes were enrolled in the study. The median age was 52.0 years (interquartile range [IQR] 43.0–60.0). The following risk factors were assessed: blood pressure, body mass index, waist circumference, physical activity, smoking, LDL-cholesterol, triglycerides, and fasting plasma glucose concentration. Total cardiovascular risk was determined as the number of uncontrolled risk factors, and with the Systemic Coronary Risk Evaluation Score (SCORE). The Functioning in the Chronic Illness Scale (FCIS) was applied to assess the physical and mental functioning of patients.

Results

The median number of measures of cardiovascular risk factors was 4.0 (IQR 3.0–5.0). The median of SCORE for the whole study population was 2.0 (IQR 1.0–3.0). Patients with lower total cardiovascular risk as defined by SCORE and number of uncontrolled risk factors had better functioning as reflected by higher FCIS (R = −0.315, p < 0.0001; R = −0.336, p < 0.0001, respectively). Multivariate logistic regression analysis identified abnormal blood pressure, abnormal waist circumference, tobacco smoking, and lack of regular physical activity to be negative predictors of functioning. Lack of regular physical activity was the only predictor of low FCIS total score (odds ratio 9.26, 95% confidence interval 1.19–71.77, p = 0.03).

Conclusions

The functioning of patients worsens as the total cardiovascular risk increases. Each of the risk factors affects the functioning of subjects without coronary artery disease with different strength, with physical activity being the strongest determinant of patient functioning.

cardiovascular risk factors
functioning of patients
==== Body
pmcIntroduction

The occurrence of chronic diseases is a serious social, health, and economic problem in Poland and in other European countries [1, 2]. It has been shown that risk factors such as poor nutrition, obesity, smoking, diabetes, hypertension, and hypercholesterolemia increase the incidence of cardiovascular events [1–3]. Undoubtedly, the occurrence of cardiovascular events in the course of a chronic disease affects multiple areas of human functioning, including physical activity, as well as the emotional and spiritual sphere. The limitations in the functioning of patients with chronic disease result in lower self-value perception, deterioration of well-being, and increased anxiety and uncertainty about the future. The degree of interference is largely dependent on the severity of disease symptoms [4, 5]. However, it is unclear whether the mere presence of risk factors in patients who have not yet experienced cardiovascular events affects their functioning.

Therefore, we assessed the impact of cardiovascular risk on the comprehensive functioning of patients without a history of atherosclerotic cardiovascular disease (CVD) enrolled into the Polish arm of the EUROASPIRE V study.

Methods

The EUROASPIRE V study is a multicenter, prospective, cross-sectional observational trial carried out in 2016–2018 in 16 European countries to determine whether the 2016 Joint European Societies’ guidelines on CVD prevention in people at high cardiovascular risk have been implemented in clinical practice. The Polish arm of the EUROASPIRE V study included 200 adults (aged 18–80 years) diagnosed with arterial hypertension, hypercholesterolemia, or diabetes within 6 to 24 months before enrolment to the study. Patients with a previous cardiovascular event were excluded from the study. Consecutive patients were identified on the basis of medical records in participating healthcare centers and were invited personally to participate in the study. All patients provided written informed consent for participation in the study. The study was approved by the Bioethical Committee of the Nicolaus Copernicus University in Torun, Collegium Medicum in Bydgoszcz (KB 586/2017). The assessment of study participants was carried out by a trained person — a nurse or a doctor during the study visit. Following the EUROASPIRE V protocol, all patients were assessed on eight different measures of risk factors: arterial blood pressure (BP), body mass index (BMI), waist circumference, physical activity, tobacco smoking status, serum total cholesterol, low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) concentration, and fasting plasma glucose.

Blood pressure was measured twice on the right shoulder in a sitting position, with the use of validated semiautomatic sphygmomanometers. The current European Society of Cardiology (ESC) criteria were applied for the diagnosis and classification of hypertension [6].

The following anthropometric measurements were taken: height (cm), weight (kg), BMI (kg/m2), and waist circumference (cm).

In order to assess physical activity, the following question was asked: “Which of the following terms best describes your extra-professional activity?”, with four possible answers: 1 — “I do not have any physical activity other than my professional work.”; 2 — “Only light physical activity most of the time.”; 3 — “Intensive physical activity at least 20 minutes 1–2 times a week. ”; and 4 — “20 minutes of vigorous physical activity more than twice a week.” Answers 3 and 4 were considered an adequate level of physical activity.

Patients’ self-declared smoking status was verified with an objective test measuring the concentration of carbon monoxide in the exhaled air, with results of > 10 parts per million (ppm) being considered indicative of active smoking.

Serum LDL-C and TG concentrations, as well as fasting plasma glucose, were measured in fasting venous blood samples on an Alinity ci analyzer (Abbott, Wiesbaden, Germany).

Appropriate control of the analyzed risk factors was acknowledged when the following criteria were met:

— Blood pressure: systolic BP < 140 mmHg and diastolic BP < 90 mmHg;

— Body weight: BMI of 20.0–24.9 kg/m2;

— Waist circumference: < 80 cm for women and < 94 cm for men;

— Regular physical activity: intensive exercise for 20 minutes or more at least 1–2 times a week;

— Smoking status: self-reported non-smoker status objectively confirmed by the concentration of carbon monoxide in the exhaled air < 10 ppm;

— LDL-C concentration: < 2.6 mmol/L (< 100 mg/dL);

— TG concentration: < 1.7 mmol/L (< 150 mg/dL);

— Fasting plasma glucose: < 100 mg/dL (< 5.6 mmol/L).

Total cardiovascular risk was determined individually for each study participant, as the number of uncontrolled risk factors, and with Systemic Coronary Risk Evaluation Score (SCORE) introduced in guidelines of the ESC [3] — a version calibrated for the Polish population [7]. The SCORE model predicts the 10-year risk of cardiovascular mortality in apparently healthy individuals based on gender, age, total cholesterol concentration, systolic BP, and smoking status [3, 7, 8]. The actual total cardiovascular risk was defined as follows: very high (SCORE ≥ 10%); high (SCORE ≥ 5% and < 10%); moderate (SCORE ≥ 1% and < 5%); and low (SCORE < 1%) [9].

We also applied the Functioning in Chronic Illness Scale (FCIS) to assess the physical and mental functioning of each patient. The FCIS is a unique tool developed for comprehensive evaluation of various aspects of patient functioning with chronic disease. It allows the diagnosis of deficit areas in patients and the implementation of appropriate interventions. This scale, consisting of 24 items, is divided into three subscales. The first part of the questionnaire assessing the impact of the disease on the patient (FCIS 1 subscale) mainly refers to the patient’s physical efficiency, quality of life, and acceptance of the disease. The second (FCIS 2 subscale) and third (FCIS 3 subscale) assess the patient’s beliefs regarding the possible impact on the course of illness and the impact of the disease on the patient’s attitudes, respectively. These subscales refer mainly to self-efficacy and the location of health control [10–12]. The FCIS total score < 79 points indicates low functioning, 79–93 points — medium functioning, and > 93 points — high functioning. Respective cut-off points for consecutive FCIS subscales scores were: < 24, 24–33, > 33 (FCIS 1); < 25, 25–29, > 29 (FCIS 2); and < 28, 28–33, > 33 (FCIS 3) [10].

In line with the EUROASPIRE V protocol, a single study visit was performed, comprising a medical interview including SCORE and FCIS evaluation, anthropometric measurements (height, weight, waist circumference), BP measurements, and measurement of blood and exhaled carbon monoxide.

In the next step the impact of total cardiovascular risk on the functioning of patients according to FCIS was evaluated.

Statistical methods

The statistical analysis was carried out using Statistica 13.0 (TIBCO Software Inc., California, USA) and MedCalc 15.8 (MedCalc Software, Ostend, Belgium). Continuous variables were presented as medians with interquartile range (IQR), and minimum and maximum value. The Shapiro-Wilk test demonstrated non-normal distribution of the investigated continuous variables. Therefore, non-parametric tests were used for statistical analysis. Comparisons between two groups were performed with the Mann-Whitney unpaired rank sum test. For comparisons between more groups, the Kruskal–Wallis one-way analysis of variance was used. To assess the relationship between two quantitative variables, Spearman’s rank correlation was used. The optimum cut-off point for the association of FCIS and high cardiovascular risk was determined using receiver operator characteristics (ROC) curve analysis. To identify factors predicting high FCIS total score univariate and multivariate logistic regression analysis were performed. The best model was identified using multiple-model backward stepwise regression. The multivariate model was created by including variables with a p value < 0.1 in univariate analysis and subsequently removing one by one those without significant impact (p > 0.05).

Results

Of 200 patients enrolled in the study, 133 (66.5%) were women. The median age of the study population was 52.0 years (IQR 43.0–60.0). The median BP for the entire population was 125.0 mmHg (IQR 118.0–135.0 mmHg) and 77.5 mmHg (IQR 70.0–82.0 mmHg) for systolic and diastolic BP, respectively. The median BMI for the entire study group was 26.0 kg/m2 (IQR 23.9–28.7 kg/m2). The median waist circumference for the entire study group was 87.0 cm (IQR 80.0–95.5 cm). Regular physical activity according to the adopted definition was declared by 41% of the study participants. The median carbon monoxide concentration measured in the exhaled air was 1.0 ppm (IQR 0.0–2.0). Active smokers (n = 30) had a significantly higher carbon monoxide concentration compared with non-smokers (4.5, IQR 2.0–8.0 vs. 1.0, IQR 0.0–1.0; p < 0.001). The level of carbon monoxide did not exceed 10 ppm in any of the patients declaring themselves as non-smokers. Median concentrations of LDL-C, TG, and glucose in the venous blood serum were 3.29 mmol/L (IQR 2.68–4.0), 1.21 mmol/L (IQR 0.90–1.55), and 5.4 mmol/L (IQR 5.04–5.90), respectively. The proportions of patients with risk factors identified according to medical records, medical history, or contemporary performed tests are shown in Table 1. The median number of measures of cardiovascular risk factors was 4.0 (IQR 3.0–5.0). The median SCORE for the whole study population was 2.0 (IQR 1.0–3.0). Measures of total cardiovascular risk are also presented in Table 1. Functioning levels assessed with the FCIS are shown in Tables 1 and 2.

Mean and median values of the FCIS total score and each subscale reflected a high functioning level (Table 2).

Patients with lower SCORE-defined total cardiovascular risk had better functioning in disease as reflected by higher FCIS total, FCIS 1, and FCIS 2, but not FCIS 3 scores (Fig. 1, 1A). The Spearman correlation between FCIS 1, 2, and 3 scores and SCORE was −0.323, p < 0.0001; −0.273, p = 0.0001; and −0.197, p = 0.005, respectively (Fig. 1, 1B). The ROC analysis (area under curve [AUC] 0.658; 95% confidence interval [CI] 0.588–0.724; p = 0.0016) revealed that patients with FCIS total score ≤ 98 are of high or very high cardiovascular risk according to SCORE, with sensitivity of 76.5% and specificity of 55.4% (Fig. 1, 1C).

In general, these results were confirmed when total cardiovascular risk was calculated as the number of uncontrolled risk factors; however, in this case the effect of total cardiovascular risk was more pronounced and significant for all FCIS subscales (Fig. 1, 2A). Spearman correlation between FCIS 1, 2, and 3 scores and the number of uncontrolled risk factors was −0.339, p < 0.0001; −0.245, p < 0.0005; and −0.289, p < 0.0001, respectively (Fig. 1, 2B). According to the ROC analysis (AUC 0.679; 95% CI 0.610–0.743; p < 0.0001), patients with an FCIS total score ≤ 97 are of high or very high cardiovascular risk as evaluated according to the number of uncontrolled risk factors, with a sensitivity of 58.1% and a specificity of 71.1% (Fig. 1, 2C).

Univariate logistic regression analysis identified abnormal BP (p = 0.002), abnormal waist circumference (p = 0.0003), tobacco smoking (p = 0.003), and lack of regular physical activity to be negative predictors of high FCIS total score (Fig. 2). These findings were confirmed in multivariate regression analysis (Table 3). For low FCIS total score, the univariate logistic regression analysis identified only a single predictor — the lack of regular physical activity (odds ratio 9.26, 95% CI 1.19–71.77, p = 0.03); therefore, the multivariate logistic regression analysis was abandoned.

Discussion

Coronary artery disease (CAD) affects multiple aspects of patients’ lives in many ways, including physical activity, emotional and spiritual spheres, and social functioning. Limited functioning of a patient with chronic disease results in decreased self-esteem, deteriorated well-being, increased anxiety, and uncertainty about the future [13–16]. Numerous studies [17–34] indicate the need for the combined use of various tools for the overall assessment of various aspects of the functioning of subjects with chronic disease. The tools previously developed to diagnose overall functioning of patients, e.g., WHO-DAS II scale and CIA questionnaire, are dedicated to very specific clinical situations, such as low back pain [17, 18] or nutrition disorders [19, 20]. The FCIS is a unique validated tool allowing the comprehensive assessment of physical and mental functioning dedicated to patients with chronic diseases. The first FCIS subscale mainly refers to the patient’s physical efficiency, quality of life, and acceptance of the disease. These aspects of patient functioning were previously evaluated in numerous studies in different clinical settings with several different tools [21–29]. The second and third FCIS subscales refer mainly to the self-efficacy and the location of health control. These aspects were assessed separately with other tools [30–34].

According to our best knowledge, this study is the first to show that the risk factors themselves affect the comprehensive functioning of patients without diagnosed CAD. The increase in total cardiovascular risk determined with the SCORE or expressed by the number of uncontrolled risk factors results in deterioration of functioning of patients as assessed with the FCIS. The scores in the FCIS subscales are generally consistent with each other, with the exception of FCIS 3 reflecting the location of health control, with regard to the SCORE scores. We have also demonstrated that an FCIS total score of 97–98 points is the cut-off for high and very high cardiovascular risk irrespective of whether it is assessed with the SCORE or the number of uncontrolled risk factors. The FCIS questionnaire was previously applied in patients with CAD [35] and in subjects with post-COVID syndrome [36]. The FCIS is currently being used in the ELECTRA-SIRIO2 study — an ongoing large-scale clinical trial scheduled to enroll a total of 4500 acute coronary syndrome patients [37, 38]. The proportion of patients with high FCIS score in our current study (64.5%) is noticeably higher than in our previous studies with CAD patients (31%) [35] and post-COVID patients (30%) [36]. We have shown that lack of regular physical activity (the strongest factor), tobacco smoking, abdominal obesity, and increased BP deteriorate the functioning of patients. Conversely, laboratory cardiovascular risk factors such as increased concentrations of LDL-C, TG, and glucose do not affect the FCIS score in multivariate regression analysis. In line with our study, Spinka et al. [39] found physical activity to be strongly correlated with the functioning and quality of life of CAD patients. Aerobic interval training as well as aerobic continuous training were shown to improve peripheral endothelial function, cardiovascular risk factors, and the quality of life [40]. Moreover, in subjects with normal coronaries, treatment of endothelial dysfunction, reflecting the cardiovascular risk and favorably influencing the quality of life [41]. We have shown increased waist circumference, but not increased BMI, to have a deteriorating impact on patient functioning. On the other hand, Oreopoulos et al. [42] revealed BMI to be inversely associated with the physical functioning and overall health-related quality of life in CAD patients, especially in individuals with severe obesity. Because the assessment of the quality of life is part of the evaluation of functioning in chronic illness, the results of the cited studies [39–42] should be considered generally consistent with our observations.

Limitations of the study

The limitation of our study is the relatively low number of enrolled patients. Moreover, the lack of follow-up did not allow for assessment of the influence of the examined risk factors on clinical outcome.

Conclusions

In conclusion, the functioning of patients worsens as the total cardiovascular risk increases. Each of the risk factors affects the functioning of subjects without CAD with different strength, with physical activity being the strongest determinant of patient functioning.

Figure 1 Functioning of patients in relation to cardiovascular risk stratified according to the SCORE and the number of uncontrolled risk factors; A. Functioning of patients according to the FCIS (subscales and total score) in a subset of patients with increasing total cardiovascular risk assessed with the SCORE (1A), expressed as the number of uncontrolled risk factors (2A); B. Spearman correlation between FCIS total score and the SCORE (1B), and the number of uncontrolled risk factors (2B); C. Discrimination of FCIS score threshold indicating patients with high or very high cardiovascular risk according to the SCORE (1C) and to the number of uncontrolled risk factors (2C)

Figure 2 Impact of single risk factors on the occurrence of high FCIS total score. Univariate regression analysis; OR — odds ratio; CI — confidence interval; LDL-C — low-density lipoprotein cholesterol; TG — triglycerides; BMI — body mass index

Table 1 Study population characteristics

The assessed feature		N	Percentage	
Age	Median (IQR)	52.0 (43.0–60.0)	
Gender	Male	67	33.5	
Female	133	66.5	
Arterial hypertension	Diagnosed	127	63.5	
Diabetes mellitus	Diagnosed	38	19.0	
Hypercholesterolemia	Diagnosed	90	45.0	
Tobacco smoking (active)	Declared	30	15.0	
Systolic blood pressure	≥ 140 mmHg	39	19.5	
Diastolic blood pressure	≥ 90 mmHg	21	10.5	
Systolic/diastolic blood pressure	≥ 140 mmHg and/or ≥ 90 mmHg	45	22.5	
Body mass index	Underweight	11	5.5	
Correct weight	72	36.0	
Overweight	84	42.0	
Obesity	33	16.5	
Waist circumference	Normal fat distribution	74	37.0	
Moderate central fat accumulation	57	28.5	
[W ≥ 80 cm, M ≥ 94 cm]			
High central fat accumulation	69	34.5	
[W ≥ 88 cm, M ≥ 102 cm]			
Physical activity	No activity	30	15.0	
Low activity	110	55.0	
Regular activity	60	30.0	
Serum LDL-C concentration	≥ 2.6 mmol/L	154	77.0	
Serum TG concentration	≥ 1.7 mmol/L	37	18.5	
Fasting plasma glucose	≥ 5.56 mmol/L	83	41.5	
Number of uncontrolled measures of CV risk factors	0	6	3.0	
1	10	5.0	
2	32	16.0	
3	35	17.5	
4	52	26.0	
5	43	21.5	
6	15	7.5	
7	5	2.5	
8	2	1.0	
SCORE	Low: < 1%	35	17.5	
Moderate: ≥ 1%; < 5%	131	65.5	
High: ≥ 5%; < 10%	16	8.0	
Very high: ≥ 10%	18	9.0	
FCIS total score	High score	129	64.5	
Medium score	51	25.5	
Low score	20	10.0	
FCIS 1 score	High score	126	63.0	
Medium score	60	30.0	
Low score	14	7.0	
FCIS 2 score	High score	106	53.0	
Medium score	71	35.5	
Low score	23	11.5	
FCIS 3 score	High score	103	51.5	
Medium score	70	35.0	
Low score	27	13.5	
IQR — interquartile range; CV — cardiovascular; LDL-C — low-density lipoprotein cholesterol; TG — triglycerides; W — women; M — men

Table 2 Results of the Functioning in Chronic Illness Scale (FCIS)

FCIS	N	Median	Quartile 1	Quartile 3	Minimum	Maximum	
FCIS total score	200	98.50	91.00	109.00	59.00	120.00	
FCIS 1 score	200	36.50	31.00	39.50	12.00	40.00	
FCIS 2 score	200	30.00	27.00	35.00	19.00	40.00	
FCIS 3 score	200	34.00	31.00	38.00	16.00	40.00	

Table 3 Predictors of high FCIS total score — multivariate logistic regression analysis

Variable	Odds ratio	95% confidence interval	P	
Abnormal blood pressure	0.47	0.22	0.99	0.0485	
Abnormal waist circumference	0.37	0.18	0.76	0.0069	
Tobacco smoking	0.36	0.15	0.88	0.0243	
Lack of regular physical activity	0.19	0.08	0.47	0.0003	

Conflict of interest: None declared.
==== Refs
References

1 Kotseva K De Backer G De Bacquer D Primary prevention efforts are poorly developed in people at high cardiovascular risk: A report from the European Society of Cardiology EURObservational Research Programme EUROASPIRE V survey in 16 European countries Eur J Prev Cardiol 2021 28 4 370 379 10.1177/2047487320908698 33966079
2 SCORE2 working group and ESC Cardiovascular risk collaboration SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe Eur Heart J 2021 42 25 2439 2454 10.1093/eurheartj/ehab309 34120177
3 Conroy R Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J 2003 24 11 987 1003 10.1016/s0195-668x(03)00114-3 12788299
4 Uchmanowicz I Lisiak M Wleklik M The relationship between frailty syndrome and quality of life in older patients following acute coronary syndrome Clin Interv Aging 2019 14 805 816 10.2147/CIA.S204121 31190767
5 Lourenço E Sampaio MR Nzwalo H Determinants of quality of life after stroke in Southern Portugal: a cross sectional community-based study Brain Sci 2021 11 11 1509 10.3390/brainsci11111509 34827509
6 Galiè N Humbert M Vachiery JL ESC Scientific Document Group 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT) Eur Heart J 2016 37 1 67 119 10.1093/eurheartj/ehv317 26320113
7 Zdrojewski T Jankowski P Bandosz P A new version of cardiovascular risk assessment system and risk charts calibrated for Polish population Kardiol Pol 2015 73 10 958 961 10.5603/KP.2015.0182 26521843
8 Tomasik T Krzysztoń J Dubas-Jakóbczyk K The systematic coronary risk evaluation (SCORE) for the prevention of cardiovascular diseases. Does evidence exist for its effectiveness? A systematic review Acta Cardiol 2017 72 4 370 379 10.1080/00015385.2017.1335052 28705107
9 Mach F Baigent C Catapano A 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk Eur Heart J 2019 41 1 111 188 10.1093/eurheartj/ehz455
10 Buszko K Pietrzykowski Ł Michalski P Validation of the Functioning in Chronic Illness Scale (FCIS) Med Res J 2018 3 2 63 69 10.5603/mrj.2018.0011
11 Kubica A Self-reported questionnaires for a comprehensive assessment of patients after acute coronary syndrome Med Res J 2019 4 2 106 109 10.5603/mrj.a2019.0021
12 Kubica A Bączkowska A Rationale for motivational interventions as pivotal element of multilevel educational and motivational project MEDMOTION Folia Cardiologica 2020 15 1 6 10 10.5603/fc.2020.0003
13 Hawkes AL Patrao TA Ware R Predictors of physical and mental health-related quality of life outcomes among myocardial infarction patients BMC Cardiovasc Disord 2013 13 69 10.1186/1471-2261-13-69 24020831
14 Assari S Moghani Lankarani M Ahmadi K Comorbidity influences multiple aspects of well-being of patients with ischemic heart disease Int Cardiovasc Res J 2013 7 4 118 123 24757635
15 Lalonde L Clarke AE Joseph L Health-related quality of life with coronary heart disease prevention and treatment J Clin Epidemiol 2001 54 10 1011 1018 10.1016/s0895-4356(01)00361-4 11576812
16 Olano-Lizarraga M Oroviogoicoechea C Errasti-Ibarrondo B The personal experience of living with chronic heart failure: a qualitative meta-synthesis of the literature J Clin Nurs 2016 25 17–18 2413 2429 10.1111/jocn.13285 27273246
17 Røe C Sveen U Bautz-Holter E Retaining the patient perspective in the international classification of functioning, disability and health core set for low back pain Patient Prefer Adherence 2008 2 337 347 10.2147/ppa.s4419 19920981
18 Garin O Ayuso-Mateos JL Almansa J Validation of the „World Health Organization Disability Assessment Schedule, WHODAS-2” in patients with chronic diseases Health Qual Life Outcomes 2010 8 51 10.1186/1477-7525-8-51 20482853
19 Bohn K Doll HA Cooper Z The measurement of impairment due to eating disorder psychopathology Behav Res Ther 2008 46 10 1105 1110 10.1016/j.brat.2008.06.012 18710699
20 Bohn K Clinical Impairment Assessment Questionnaire (CIA) Encyclopedia of Feeding and Eating Disorders Springer Singapore 2017 126 129
21 Carson P Tam SW Ghali JK Relationship of quality of life scores with baseline characteristics and outcomes in the African-American heart failure trial J Card Fail 2009 15 10 835 842 10.1016/j.cardfail.2009.05.016 19944359
22 Juenger J Schellberg D Kraemer S Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables Heart 2002 87 3 235 241 10.1136/heart.87.3.235 11847161
23 Kurpas D Mroczek B Knap-Czechowska H Quality of life and acceptance of illness among patients with chronic respiratory diseases Respir Physiol Neurobiol 2013 187 1 114 117 10.1016/j.resp.2013.02.009 23419519
24 Jankowska-Polańska B Kaczan A Lomper K Symptoms, acceptance of illness and health-related quality of life in patients with atrial fibrillation Eur J Cardiovasc Nurs 2018 17 3 262 272 10.1177/1474515117733731 28933196
25 Lewko J Polityńska B Kochanowicz J Quality of life and its relationship to the degree of illness acceptance in patients with diabetes and peripheral diabetic neuropathy Adv Med Sci 2007 52 Suppl 1 144 146 18229653
26 Benetos A Gautier S Labat C Mortality and cardiovascular events are best predicted by low central/peripheral pulse pressure amplification but not by high blood pressure levels in elderly nursing home subjects: the PARTAGE (Predictive Values of Blood Pressure and Arterial Stiffness in Institutionalized Very Aged Population) study J Am Coll Cardiol 2012 60 16 1503 1511 10.1016/j.jacc.2012.04.055 22999729
27 Pedrosa H De Sa A Guerreiro M Functional evaluation distinguishes MCI patients from healthy elderly people — the ADCS/MCI/ADL scale J Nutr Health Aging 2010 14 8 703 709 10.1007/s12603-010-0102-1 20922349
28 Devlin NJ Brooks R EQ-5D and the EuroQol group: past, present and future Appl Health Econ Health Policy 2017 15 2 127 137 10.1007/s40258-017-0310-5 28194657
29 Oris L Luyckx K Rassart J Illness identity in adults with a chronic illness J Clin Psychol Med Settings 2018 25 4 429 440 10.1007/s10880-018-9552-0 29468569
30 Sengul Y Kara B Arda MN The relationship between health locus of control and quality of life in patients with chronic low back pain Turk Neurosurg 2010 20 2 180 185 10.5137/1019-5149.JTN.2616-09.1 20401846
31 Wielenga-Boiten JE Heijenbrok-Kal MH Ribbers GM The relationship of health locus of control and health-related quality of life in the chronic phase after traumatic brain injury J Head Trauma Rehabil 2015 30 6 424 431 10.1097/HTR.0000000000000128 25699627
32 Cramm JM Strating MMH Roebroeck ME The importance of general self-efficacy for the quality of life of adolescents with chronic conditions Soc Indic Res 2013 113 1 551 561 10.1007/s11205-012-0110-0 23874059
33 Maeda U Shen BJ Schwarz ER Self-efficacy mediates the associations of social support and depression with treatment adherence in heart failure patients Int J Behav Med 2013 20 1 88 96 10.1007/s12529-011-9215-0 22212607
34 Moljord IE Lara-Cabrera ML Perestelo-Pérez L Psychometric properties of the Patient Activation Measure-13 among out-patients waiting for mental health treatment: A validation study in Norway Patient Educ Couns 2015 98 11 1410 1417 10.1016/j.pec.2015.06.009 26146239
35 Michalski P Kasprzak M Kosobucka A Sociodemographic and clinical determinants of the functioning of patients with coronary artery disease Med Res J 2021 6 1 21 27 10.5603/mrj.a2021.0003
36 Kubica A Michalski P Kasprzak M Functioning of patients with post-COVID syndrome — preliminary data Med Res J 2021 6 3 224 229 10.5603/mrj.a2021.0044
37 Kubica A Adamski P Bączkowska A The rationale for Multilevel Educational and Motivational Intervention in Patients after Myocardial Infarction (MEDMOTION) project is to support multicentre randomized clinical trial Evaluating Safety and Efficacy of Two Ticagrelor-based De-escalation Antiplatelet Strategies in Acute Coronary Syndrome (ELECTRA – SIRIO 2) Med Res J 2020 5 4 244 249 10.5603/mrj.a2020.0043
38 Kubica J Adamski P Gorog DA Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial Cardiol J 2022 29 1 148 153 10.5603/CJ.a2021.0118 34622433
39 Spinka F Aichinger J Wallner E Functional status and life satisfaction of patients with stable angina pectoris in Austria BMJ Open 2019 9 9 e029661 10.1136/bmjopen-2019-029661 31488483
40 Pattyn N Vanhees L Cornelissen VA The long-term effects of a randomized trial comparing aerobic interval versus continuous training in coronary artery disease patients: 1-year data from the SAINTEX-CAD study Eur J Prev Cardiol 2016 23 11 1154 1164 10.1177/2047487316631200 26858279
41 Reriani M Flammer AJ Duhé J Coronary endothelial function testing may improve long-term quality of life in subjects with microvascular coronary endothelial dysfunction Open Heart 2019 6 1 e000870 10.1136/openhrt-2018-000870 30815267
42 Oreopoulos A Padwal R McAlister FA Association between obesity and health-related quality of life in patients with coronary artery disease Int J Obes (Lond) 2010 34 9 1434 1441 10.1038/ijo.2010.73 20386551
